Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06262880 · ClinicalTrials.gov registry record · NA
Dietary Supplementation on Gastrointestinal Barrier Function
A NA study of Intestinal Permeability, sponsored by Brightseed.
- Recruiting
- Registry status
- NA
- Development phase
- 126
- Enrollment target
- 1
- Study location
NCT06262880: Recruiting NA study of Intestinal Permeability, sponsored by Brightseed.
NCT06262880 is a NA study of Intestinal Permeability that is actively recruiting participants, run by Brightseed. The registered enrollment target is 126 participants, above the 24-participant average among 3 other Intestinal Permeability trials with a reported enrollment target (425% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06262880, a NA study of Intestinal Permeability, is actively recruiting participants, sponsored by Brightseed.
- RECRUITING
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the current study is to examine the effects of a dietary supplement containing plant derived phenolics at two different dose levels on parameters of gastrointestinal (GI) health in otherwise generally healthy adults with risk factors (high BMI and waist circumference) for increased GI permeability. The primary hypothesis is that supplementation with plant derived phenolics will improve gut health compared to placebo.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT plant derived phenolics
- OTHER Microcrystaline cellulose (MCC)
Study Locations (1)
Illinois
- Biofortis - Addison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2024-02-06 |
| Est. Completion | 2025-02-06 |
| Phase | NA |
What NCT06262880 shows while recruiting
NCT06262880 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, above the 24-participant average among 3 other Intestinal Permeability trials with a reported enrollment target (425% higher).
The record links to 1 condition, with Intestinal Permeability appearing as the primary indexed condition, and to 2 interventions - of which plant derived phenolics is the first listed.
NCT06262880 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06262880 about?
NCT06262880 is a clinical study titled "Dietary Supplementation on Gastrointestinal Barrier Function". The purpose of the current study is to examine the effects of a dietary supplement containing plant derived phenolics at two different dose levels on parameters of gastrointestinal (GI) health in otherwise generally healthy adults with risk factors (high BMI and waist circumference) for increased GI...
What is the current status of trial NCT06262880?
This trial is currently recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2024-02-06. Estimated completion is 2025-02-06.
What conditions does trial NCT06262880 study?
This clinical trial studies the following conditions: Intestinal Permeability.
What interventions are being tested in trial NCT06262880?
The interventions under investigation include: plant derived phenolics (DIETARY_SUPPLEMENT), Microcrystaline cellulose (MCC) (OTHER).
Who is sponsoring clinical trial NCT06262880?
This trial is sponsored by Brightseed, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06262880 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intestinal Permeability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI